Helle Hjorth Johannesen

Helle Hjorth Johannesen

Guest researcher


  1. 2010
  2. Published

    The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan

    Spindler, K. G., Vittrup, B. V., Christensen, I. C., Schou, J. S., Jakobsen, A. J., Høgdall, Estrid Vilma Solyom, Pallisgaard, N., Nielsen, D. N., Johannesen, Helle Hjorth & Johansen, J. H., 2010, In: Annals of Oncology. 21, p. I39-I39

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

ID: 283297065